Nemes Rush Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $692K | Sell |
28,544
-86,066
| -75% | -$2.09M | 0.08% | 109 |
|
|
2025
Q1 | $2.9M | Sell |
114,610
-12,251
| -10% | -$310K | 0.37% | 56 |
|
|
2024
Q4 | $3.37M | Buy |
126,861
+10,189
| +9% | +$270K | 0.42% | 53 |
|
|
2024
Q3 | $3.24M | Sell |
116,672
-24,358
| -17% | -$676K | 0.47% | 48 |
|
|
2024
Q2 | $3.95M | Buy |
141,030
+23,281
| +20% | +$651K | 0.54% | 45 |
|
|
2024
Q1 | $3.27M | Buy |
117,749
+47,622
| +68% | +$1.32M | 0.47% | 48 |
|
|
2023
Q4 | $2.02M | Sell |
70,127
-3,455
| -5% | -$99.5K | 0.33% | 58 |
|
|
2023
Q3 | $2.44M | Buy |
73,582
+2,918
| +4% | +$96.8K | 0.44% | 53 |
|
|
2023
Q2 | $2.59M | Buy |
+70,664
| New | +$2.59M | 0.46% | 54 |
|